| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 3,105 | 3,260 | | Cost of Revenue |
-
|
-
| | | Gross Profit | 3,105 | 3,260 | | | Operating Expenses | | Research Development | 16,500 | 15,817 | | Selling General and Administrative | 5,479 | 7,975 | | Non Recurring |
-
|
-
| | Others | 218 | 283 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (19,092) | (20,815) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,195 | 3,608 | | Earnings Before Interest And Taxes | (17,898) | (17,207) | | Interest Expense | 94 | 1,719 | | Income Before Tax | (17,992) | (18,926) | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (17,992) | (18,926) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (17,992) | (18,926) | | Preferred Stock And Other Adjustments |
-
| (5,459) | | | Net Income Applicable To Common Shares | ($17,992) | ($24,385) |
|
0.29% Nasdaq 
0.01 (0.99%) 
Income Statement
